JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 50:768-777, doi:10.1016/j.jacc.2007.04.064 (Published online 6 August 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Appendix
Right arrow Cardiosource Slide Set
Right arrow All Versions of this Article:
j.jacc.2007.04.064v1
50/8/768    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fonarow, G. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fonarow, G. C.

CLINICAL RESEARCH: HEART FAILURE

Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure

A Report From the OPTIMIZE-HF Registry

Gregg C. Fonarow, MD, FACC*,*, Wendy Gattis Stough, PharmD{dagger}, William T. Abraham, MD, FACC{ddagger}, Nancy M. Albert, PhD, RN§, Mihai Gheorghiade, MD, FACC||, Barry H. Greenberg, MD, FACC, Christopher M. O’Connor, MD, FACC#, Jie Lena Sun, MS**, Clyde W. Yancy, MD, FACC{dagger}{dagger}, James B. Young, MD, FACC{ddagger}{ddagger} for the OPTIMIZE-HF Investigators and Hospitals

* Department of Medicine, UCLA Medical Center, Los Angeles, California
{dagger} Department of Medicine, Duke University Medical Center, Durham, North Carolina, and Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
{ddagger} Division of Cardiology, Ohio State University, Columbus, Ohio
§ George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
|| Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
Department of Medicine, USCD Medical Center, San Diego, California
# Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina
** Duke Clinical Research Institute, Durham, North Carolina
{dagger}{dagger} Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas (formerly Department of Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas)
{ddagger}{ddagger} Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio.

Manuscript received December 12, 2006; revised manuscript received April 20, 2007, accepted April 23, 2007.

* Reprint requests and correspondence: Dr. Gregg C. Fonarow, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, California 90095-1679. (Email: gfonarow{at}mednet.ucla.edu).

Objectives: We sought to evaluate the characteristics, treatments, and outcomes of patients with preserved and reduced systolic function heart failure (HF).

Background: Heart failure with preserved systolic function (PSF) is common but not well understood.

Methods: This analysis of the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry compared 20,118 patients with left ventricular systolic dysfunction (LVSD) and 21,149 patients with PSF (left ventricular ejection fraction [EF] ≥40%). Sixty- to 90-day follow-up was obtained in a pre-specified 10% sample of patients. Analyses of patients with PSF defined as EF >50% were also performed for comparison.

Results: Patients with PSF (EF ≥40%) were more likely to be older, female, and Caucasian and to have a nonischemic etiology. Although length of hospital stay was the same in both groups, risk of in-hospital mortality was lower in patients with PSF (EF ≥40%) (2.9% vs. 3.9%; p < 0.0001). During 60- to 90-day post-discharge follow-up, patients with PSF (EF ≥40%) had a similar mortality risk (9.5% vs. 9.8%; p = 0.459) and rehospitalization rates (29.2% vs. 29.9%; p = 0.591) compared with patients with LVSD. Findings were comparable with those with PSF defined as EF >50%. In a risk- and propensity-adjusted model, there were no significant relationships between discharge use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or beta-blocker and 60- to 90-day mortality and rehospitalization rates in patients with PSF.

Conclusions: Data from the OPTIMIZE-HF registry reveal a high prevalence of HF with PSF, and these patients have a similar post-discharge mortality risk and equally high rates of rehospitalization as patients with HF and LVSD. Despite the burden to patients and health care systems, data are lacking on effective management strategies for patients with HF and PSF. (Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure [OPTIMIZE-HF]); http://www.clinicaltrials.gov/ct/show/NCT00344513?order=1; NCT00344513 [ClinicalTrials.gov] )

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  ARB = angiotensin receptor blocker
  EF = ejection fraction
  HF = heart failure
  LVSD = left ventricular systolic dysfunction
  PSF = preserved systolic function




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. R. Di Tullio
Diastolic Dysfunction: Does Ethnicity Matter?
J. Am. Coll. Cardiol., September 16, 2008; 52(12): 1022 - 1023.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
R. O. Bonow
Measuring Quality in Heart Failure: Do We Have the Metrics?
Circ Cardiovasc Qual Outcomes, September 1, 2008; 1(1): 9 - 11.
[Full Text] [PDF]


Home page
JAMAHome page
S. J. Shah and M. Gheorghiade
Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA, July 23, 2008; 300(4): 431 - 433.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. S. Ross, G. K. Mulvey, B. Stauffer, V. Patlolla, S. M. Bernheim, P. S. Keenan, and H. M. Krumholz
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Arch Intern Med, July 14, 2008; 168(13): 1371 - 1386.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Beohar, A. K. Erdogan, D. C. Lee, H. N. Sabbah, M. J. Kern, J. Teerlink, R. O. Bonow, and M. Gheorghiade
Acute heart failure syndromes and coronary perfusion.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 13 - 16.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
G. C. Fonarow, C. W. Yancy, N. M. Albert, A. B. Curtis, W. G. Stough, M. Gheorghiade, J. T. Heywood, M. L. McBride, M. R. Mehra, C. M. O'Connor, et al.
Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF
Circ Heart Fail, July 1, 2008; 1(2): 98 - 106.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. E. Wolfel
Can We Predict and Prevent the Onset of Acute Decompensated Heart Failure?
Circulation, October 2, 2007; 116(14): 1526 - 1529.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.